We have observed
12 EP applications
David Christopher Holland
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after October 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
TREATMENT OF CIRCADIAN RHYTHM DISORDERS
DERIVATIVES OF SOBETIROME
METHOD FOR SOLUTION PHASE DETRITYLATION OF OLIGOMERIC COMPOUNDS
CORTISTATIN ANALOGUES, SYNTHESES, AND USES THEREOF
TARGETED SELECTION OF PATIENTS FOR TREATMENT WITH CORTISTATIN DERIVATIVES
METHODS TO PREVENT TISSUE COLONIZATION OF PATHOGENS AND FOR TREATMENT OF BIOFILMS ON ANIMAL TISSUES
MODIFIED CRISPR RNA AND MODIFIED SINGLE CRISPR RNA AND USES THEREOF
CORTISTATIN ANALOGUES AND SYNTHESES AND USES THEREOF
OLIGOMERIC COMPOUNDS COMPRISING BICYCLIC NUCLEOTIDES AND USES THEREOF
RATIONAL COMBINATION THERAPY FOR THE TREATMENT OF CANCER
MODULATING APOLIPOPROTEIN (a) EXPRESSION
CONJUGATED ANTISENSE COMPOUNDS FOR USE IN THERAPY